XML 61 R32.htm IDEA: XBRL DOCUMENT v3.25.3
Research and Development (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Jul. 31, 2025
Dec. 31, 2024
Research and Development Arrangement, Contract to Perform for Others [Line Items]            
Research and development expenses $ 1,244,000 $ 48,000 $ 1,395,000 $ 143,000    
Accounts payable-license agreements - past due 3,167,000   $ 3,167,000   $ 3,167,000 $ 2,433,000
Research and developmentroyalty rates description     Under the amended agreements, royalty rates are structured as follows: 7% on the first $20 million of applicable net sales, 6% on sales between $20 million and $40 million, 5% on sales between $40 million and $100 million, and 4% on sales in excess of $100 million. These rates apply both during the initial term of the agreements and throughout the “Extended Term,” defined as a period of at least ten (10) years      
Penalty interest     $ 36,000 36,000    
Revenues 0 $ 0 0 0    
License Agreements [Member]            
Research and Development Arrangement, Contract to Perform for Others [Line Items]            
Research and development expenses     698,000 141,000    
License Agreements [Member]            
Research and Development Arrangement, Contract to Perform for Others [Line Items]            
Total outstanding fees $ 2,236,000   2,236,000     $ 931,000
AOT Prototypes [Member]            
Research and Development Arrangement, Contract to Perform for Others [Line Items]            
Research and development expenses     697,000 2,000    
License Agreements [Member]            
Research and Development Arrangement, Contract to Perform for Others [Line Items]            
Revenues     $ 0 $ 0